Review Article
Adjuvant Treatment of Melanoma
Table 7
Melanomas. Adjuvant treatment with vaccines. Randomised studies [
20].
| Authors | No. of cases | Stage | Treatment | Followup (years) | Statistical significance |
| Livingston 1994 | 123 | III | GM2 + BCG + CFM | 5 y. | NS | BCG + CFM | Wallack 1995 | 250 | II | Virus allogeneic polyvalent melanoma cell lysate | 2.5 y. | NS | Wallack 1998 | 250 | III | Melanoma cell lysate vaccine | 3 y. | NS | Bystryn 2001 | 38 | III | Polyvalent shed antigen | 2.5 y. | S | Placebo | Sondak 2002 | 689 | IIA | Melacine and DETOX | 5.6 y. | NS | Observation | Hershey | 700 | IIB | Cell lysate vaccine | 8 y. | Tendency in RFS/GS | Placebo |
|
|